Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ·Healthcare·Biotechnology
$4.10
+3.02%
Mkt Cap $7.91M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$4.00
Range $1.00 – $7.00
Implied Upside
-2.4%
Consensus $4.00 vs current $4.10
NASDAQ·Healthcare·Biotechnology
$4.10
+3.02%
Mkt Cap $7.91M
No recent rating data.
Price Target (2 analysts)
$4.00
Range $1.00 – $7.00
-2.4%
Consensus $4.00 vs current $4.10